pGL4.18 CMV-Luc Citations (3)

Originally described in: Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening.
Grohar PJ, Woldemichael GM, Griffin LB, Mendoza A, Chen QR, Yeung C, Currier DG, Davis S, Khanna C, Khan J, McMahon JB, Helman LJ J Natl Cancer Inst. 2011 Jun 22;103(12):962-78. doi: 10.1093/jnci/djr156. Epub 2011 Jun 8. PubMed Journal

---

Articles Citing pGL4.18 CMV-Luc

Articles
Targeting Hippo-Dependent and Hippo-Independent YAP1 Signaling for the Treatment of Childhood Rhabdomyosarcoma. Slemmons KK, Yeung C, Baumgart JT, Juarez JOM, McCalla A, Helman LJ. Cancer Res. 2020 Jul 15;80(14):3046-3056. doi: 10.1158/0008-5472.CAN-19-3853. Epub 2020 Apr 30. PubMed
Pharmacological Regulation of Heat Shock Response via Aptamer-Antidote Couple. Kaur J, Roy I. ACS Chem Neurosci. 2025 Jun 4;16(11):2024-2034. doi: 10.1021/acschemneuro.4c00865. Epub 2025 May 19. PubMed
Electromagnetic field-inducible in vivo gene switch for remote spatiotemporal control of gene expression. Kim J, Hwang Y, Kim S, Kwon D, Park J, Cho B, An S, Kang S, Kim Y, Kim S, Lengner CJ, Kim S, Kwon Y, Sung JS, Kim J. Cell. 2026 May 28;189(11):3465-3480.e23. doi: 10.1016/j.cell.2026.03.029. Epub 2026 Apr 14. PubMed

If you have published an article using this material, please email us at to have your article added to this page.